These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma. Gonzalez-Meljem JM; Haston S; Carreno G; Apps JR; Pozzi S; Stache C; Kaushal G; Virasami A; Panousopoulos L; Mousavy-Gharavy SN; Guerrero A; Rashid M; Jani N; Goding CR; Jacques TS; Adams DJ; Gil J; Andoniadou CL; Martinez-Barbera JP Nat Commun; 2017 Nov; 8(1):1819. PubMed ID: 29180744 [TBL] [Abstract][Full Text] [Related]
3. Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis. Gonzalez-Meljem JM; Martinez-Barbera JP Cell Mol Life Sci; 2021 May; 78(10):4521-4544. PubMed ID: 34019103 [TBL] [Abstract][Full Text] [Related]
11. Pivotal role of NF-κB in cellular senescence of experimental pituitary tumours. Mongi-Bragato B; Grondona E; Sosa LDV; Zlocowski N; Venier AC; Torres AI; Latini A; Leal RB; Gutiérrez S; De Paul AL J Endocrinol; 2020 May; 245(2):179-191. PubMed ID: 32092035 [TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice. Apps JR; Martinez-Barbera JP Neurosurg Focus; 2016 Dec; 41(6):E4. PubMed ID: 27903120 [TBL] [Abstract][Full Text] [Related]
13. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. Rickert CH; Paulus W J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):260-1. PubMed ID: 12531965 [TBL] [Abstract][Full Text] [Related]
14. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918 [TBL] [Abstract][Full Text] [Related]
15. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma. Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-1α leads to growth hormone deficiency in adamantinomatous craniopharyngioma by targeting pericytes: implication in pituitary fibrosis. Mao J; Qiu B; Mei F; Liu F; Feng Z; Fan J; Nie J; Huang L; Liao X; Wang Z; Zeng J; Weng Z; Zang N; Qi S; Bao Y Metabolism; 2019 Dec; 101():153998. PubMed ID: 31666193 [TBL] [Abstract][Full Text] [Related]
17. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue. Thimsen V; John N; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Knosp E; Losa M; Buslei R; Hölsken A Sci Rep; 2017 Nov; 7(1):15856. PubMed ID: 29158570 [TBL] [Abstract][Full Text] [Related]